PRTK Stock: Paratek Pharmaceuticals, Inc. Stock Price, Analysis & Insights

Get live PRTK stock price $2.23, comprehensive Paratek Pharmaceuticals, Inc. stock analysis, charts, news, and expert forecast. Real-time PRTK stock data and investment insights.

Quick links:Financial Metrics•Earnings•Analyst Forecasts•Financials•Technicals

2.23

1.83%Today

PRTK • Paratek Pharmaceuticals, Inc. • NASDAQ Global Market • Healthcare

Market Cap

127.83M

Volume

4.48M

52W High

3.65

52W Low

1.29

Loading chart data...

Investment Score

Annual (latest period)

Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

View full dashboardUnlock quarterlyFaster signals · Pro+

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Paratek Pharmaceuticals, Inc., a biopharmaceutical firm headquartered in Boston, Massachusetts, and founded in 1996, is actively engaged in the commercialization of its products. The company's core mission involves the creation and market introductio...

Contact Information

Website: https://paratekpharma.com
Address: 75 Park Plaza
Country: US

Investment Analysis & Business Insights

Healthcare

Biotechnology

Investment Highlights

✓ Strong presence in the Healthcare sector with established market position

✓ Higher growth potential with elevated volatility (Beta: 1.70)

Important Investment Considerations

⚠All investments carry risk, including potential loss of principal for Paratek Pharmaceuticals, Inc. shareholders
⚠Market volatility can significantly impact stock price, especially for smaller companies
⚠Sector-specific risks in Healthcare may affect company performance
⚠Past performance does not guarantee future results for Paratek Pharmaceuticals, Inc.
⚠Investors should consider how Paratek Pharmaceuticals, Inc. fits within their overall portfolio allocation
⚠Valuation metrics suggest potential, but require fundamental analysis

Market Cap

127.83M

P/E Ratio (TTM)

-2.01

Beta

1.70

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

Related Stocks

Compare PRTK with peer companies:

aTyr Pharma, Inc. (ATYR)

Price: $0.46
Market cap: 45.06M

Decibel Therapeutics, Inc. (DBTX)

Price: $4.91
Market cap: 123.37M

Graybug Vision, Inc. (GRAY)

Price: $5.50
Market cap: 120.98M

Kinnate Biopharma Inc. (KNTE)

Price: $2.65
Market cap: 124.99M

NGM Biopharmaceuticals, Inc. (NGM)

Price: $1.54
Market cap: 128.53M

Pardes Biosciences, Inc. (PRDS)

Price: $2.18
Market cap: 135.19M

Quoin Pharmaceuticals, Ltd. (QNRX)

Price: $5.00
Market cap: 10.04M

Selecta Biosciences, Inc. (SELB)

Price: $0.88
Market cap: 135.20M

Sesen Bio, Inc. (SESN)

Price: $0.63
Market cap: 127.96M

Tourmaline Bio, Inc. (TRML)

Price: $47.98
Market cap: 1.23B

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.